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Objective. To compare the eﬀect of two intraoral devices (titratable oral appliance-Klearway (KW) and mandibular advancement
splint (MAS)) in mild and moderate obstructive sleep apnea (OSA) patients. Method and Materials. The study group was
comprised of twenty-four adult volunteer patients with OSA. Twelve subjects were ﬁtted with a titratable oral appliance (group
KW) protruding the mandible (85% of maximum protrusion). The other 12 subjects received MAS with 75% protrusion of the
mandible (group MAS). Baseline, (“0.PSG”), ﬁrst week (K1.PSG for KW group and M1.PSG for MAS group), and after the ﬁrst
month(K2.PSGforKWgroupandM2 .PSGforMASgroup).Results.Bothgroupsproduced similarreduction inapnea-hypopnea
index (AHI) from baseline till the end of the ﬁrst week and ﬁrst month (P<. 05). However, the success rate of both groups at the
end of the ﬁrst month was found to be statistically diﬀerent from the success rate of the ﬁrst week (P<. 05). The reduction in
mean AHI of group KW-moderate (KW-mo) was signiﬁcantly diﬀerent from the mean AHI of group MAS-moderate (MAS-mo)
at the end of the ﬁrst month (P<. 05). Conclusion. This study suggests that Klearway appliance was more eﬀective in treating
moderate OSA patients than MAS appliance. It was concluded that an appliance that provides 85% mandibular advancement to
open the upper airway was more eﬀective in reducing the number of high apneic events during sleep in comparison to the one
which provides 75%.
1.Introduction
Snoring and obstructive sleep apnea syndrome (OSAS) are
common disorders related with the narrowing of the upper
airway. Many treatment methods have been tried over the
years to treat snoring and obstructive sleep apnea (OSA) [1].
Today, three approaches, namely, nasal continuous positive
airway pressure (nCPAP), surgical techniques, and use of
intraoral appliances(OAs) seem to be themost eﬀectiveones
[2–5].
Intra-OAs are indicated in patients with primary snoring
orhaving mild OSAwho donotrespond toorare not appro-
priate candidates for treatment with behavioral measures
such as weight loss or change of sleep position. On the other
hand, OAs have been advised for patients with moderate to
severe OSA who cannot tolerate or refuse treatment with
nCPAP or subjects who are not suitable surgical candidates
[6, 7]. Intra-OAs are worn in the mouth during sleep to
prevent the oropharyngeal tissues and the base of the tongue
from collapsing and obstructing the airway [8–11].
Mandibular advancement splint (MAS) is a nonad-
justable, one-piece appliance (monoblock) and functions to
repose and maintain the mandible in a protruded position
and vertical opening between 5 and 7mm during sleep
[2, 8, 11–13]. Titratable OA is an adjustable, two-piece
appliance. Among these devices, Klearway appliance is the
most thoroughly researched OA for treatment of snoring
and OSAS [12–16]. Both appliances are mandibular repo-
sitioners (MRs) that advance the mandible and tongue base,
increasing the space between the base of the tongue and the
posterior pharyngeal wall.
Lawton et al. [15] compared the Twin Block and
Herbst mandibular advancement splint in the treatment of
patients with obstructive sleep apnea. They found that both2 ISRN Dentistry
appliances were eﬀective on the AHI, snoring frequency,
arterial blood oxygen saturation, quality of life, and side-
eﬀects. On the other hand, side eﬀects with both appliances
were minor and improved in longer term. Kuna et al. [16]
compared the polysomnographic results of EMA-T (elastic
mandibular advancement) appliance and Klearway in the
long-term treatment. They observed that the mean AHI
decreased from 17.8events/h at the baseline to 4.2events/hr
at 6 to 12 weeks of treatment, to 8.2events/hr after 6 to 12
months of treatment, and to 8.3events/hr 18 to 24 months
later.
Our aim was to evaluatethe eﬀectsof MASand Klearway
appliance on OSA patients by comparing the AHI results
at diﬀerent time intervals and to investigate patients’ short-
term compliances.
2.Materialsand Methods
A total of 24 OSA patients participated in the study. The
mean age was 39 ± 4.2. The mean body mass index was
32.3 ± 5.1kg/m 2, and the mean neck size was 42 ± 3.5cm.
The patients were referred from the Council of the Sleep-
Respiration Disorders of Ege University Medical Faculty
Research Hospital with a history and diagnosis of intrusive
snoring and obstruction in their sleep, and their history was
taken accordingly with the following areas of interest, by
the Department of Chest Diseases, Faculty of Medicine, Ege
University.
2.1. Diagnosis. The results of the patient’s history showed
that the patients
(i) had severe snoring problems on the back position
and daytime drowsiness;
(ii) witnessed apneas, blockage feeling, perspiration dur-
ing sleep, and insomnia;
(iii) had morning headaches and dryness in mouth;
(iv) did not have addiction to sedatives, alcohol, or
smoking;
(v) were treated for hypertension and diabetes mellitus
Type 2.
Dental examination of the patients consisted of the
following: study casts and panoramic radiograph. The tem-
poromandibular joint (TMJ) evaluation such as palpation,
auscultation, and evaluation of dentition and occlusion were
applied. Muscle palpation and motion range of the jaw, such
asmaximumopening(40–60mm)andlateralandprotrusive
movement (>8mm) were also evaluated. All of the patients
had more than 10 teeth in each jaw and had no symptoms of
temporomandibulardisorder. Oral health ofthe patientswas
examined before treatment, and their acute problems were
eliminated by basic dental treatments before participation in
the study.
Sleep study with a baseline overnight polysomnog-
raphy (PSG) in sleep laboratory revealed an obstructive
apnea/hypopnea index (AHI) between 5 and 40 events per
hour during patients’ sleep (including no central or mixed
OSA patients). The ﬁrst half of 24 patients, who refused
and/or not tolerated the use of nCPAP device, had mild
OSAS, whereas the second half of the patients had moderate
O S A S( A H Io f5t o2 0i sc o n s i d e r e dm i l d ,a n d2 1t o4 0
is moderate according to the American Academy of Sleep
Medicine) [9].
In the study, 24 OSA patients were divided into two
groups (group KW and group MAS). In the group KW,
twelve subjects, including 6 mild (KW-mi) and 6 moderate
(KW-mo)OSAS,usedKlearwayappliancewith5mmvertical
dimension (Figure 1)[ 10, 14]. Klearway appliance had an
expansion screw in the palate. The dentist advanced the
appliance by 0.5mm increments per week. It was fabricated
from thermoactive acrylic, increasing retention and decreas-
ing tooth discomfort. It also permitted lateral and vertical
jaw movements. The other 12 subjects, including 6 mild
(MAS-mi) and 6 moderate (MAS-mo)OSASs,received MAS
with 75% protrusion of the mandible and 5mm vertical
dimension (group MAS) (Figure 2). Mandibular advance-
mentsplintwasmadefrom rigidacrylic. Theventilationhole
was placed in the anterior portion of the appliances to allow
easy respiration throughout the night [2, 6, 8, 11, 15].
Informed consent was obtained from all patients. The
experiments were conducted in accordance with the princi-
ples of the Declaration of Helsinki for Human Experimenta-
tion.
2.2. Protocol (data collection). Five nighttime polysomno-
grams were performed.
(0.PSG): All patients underwent ﬁrst-night polysom-
nogram without using any appliance.
(PSG. K1): The ﬁrst week of control Polysomnogram
performed to Group K
(PSG. K2): Third control polysomnogram after one
month of Klearway usage.
(PSG.M1):The ﬁrstweekofcontrolpolysomnogram
performed to group M.
(PSG. M2): Third control polysomnogram after one
month of MAS usage.
All subjects completed the Epworth Sleepiness Score
(ESS) before the usage of appliances and at the end of the
month during which the appliances were used.
2.3. Statistical Analysis. The data were analyzed by using
SPSSsoftware (SPSS,Chicago,III).Within-group diﬀerences
before and after the appliance usage were evaluated by the
Wilcoxon signed-ranks test.
As a result of the 3-way ANOVA analysis made to
compare the results of AHI among the diﬀerent time
intervals in all groups, statistical diﬀerences at a level of
P<. 05 were found. In order to determine from which time
interval this diﬀerence came from, Tukey HSD test was used.
Statistical diﬀerences were evaluated in terms of P<. 05.ISRN Dentistry 3
(a) (b)
(c)
Figure 1: Titratable appliance (Klearway).
(a) (b)
Figure 2: Mandibular advancement splint (MAS).
3.Results
Each subject underwent 3 sleep studies after the usage of
eachappliance.AdjustmentoftheKappliancewascontinued
until the subjective signs and symptoms of OSAS were
reduced or disappeared. Three of the 12 subjects required no
advancement beyond 75% maximum protrusion position in
group KW. The mean total amount of mandibular advance-
ment was 9.4 ± 1.3mm (85%), and vertical dimension
between the mandible and maxilla was 5mm.
The MAS appliance was fabricated with a position of
75% of maximum protrusion and 5mm vertical dimension.
Three of the 12 patients in group MAS and one of the 12
patients in group KW described mild pain in the TMJ and
muscle tenderness. However, it improved to be only slightly
uncomfortable over time. On the other hand, gum irritation
was only observed in three patients of group MAS. Two
patientsofgroupKWcomplainedaboutloweranteriortooth
discomfort in the morning. However, these complaints in
both group KW and MAS disappeared after a week.
The median initial ESS reduced from 11.25±0.7t o4 .7±
1.0 in group KW at the end of the ﬁrst month (P<. 001).
Reduction in ESS was also observed at the end of the ﬁrst
month from 11.1±1.7to4.5±0.9ingr oupMAS(P = .003 <
.01).Allsubjectssubjectivelyreportedmorerestfulsleepwith
reduction ofsnoring both at the end ofthe ﬁrst week and the
ﬁrst month.
Polysomnographic data results as Mean±SD and statisti-
cal signiﬁcance are shown in Tables 1 and 2.T h em e a nA H I
statistically decreased in both groups (P<. 05). Using PSG
data, there was no change in total sleep time, but the mean
REMtimeduring sleepincreased inboththegroupstheboth
at the end of the ﬁrst week and the ﬁrst month (P<. 05).
However, there was no change in non-REM time during
sleep, or time spent in the supine position while asleep in
both the groups. In addition, the mean oxygen saturation
(SaO2) improved in the both group KW and Group MAS at
the diﬀerent time intervals (P<. 05).
Comparison of the AHI at diﬀerent time intervals for
each group is shown in Table 3. Statistically signiﬁcant4 ISRN Dentistry
Table 1: Polysomnographicresults of Klearway appliance group.
NORMS (N = 12) 0.PSG PSG.K1 0.PSG-PSG.K1 PSG.K2 0.PSG-PSG.K2 PSG.K1-PSG.K2
PP P
Total sleep time (mins.) 227.6 ±101.9 289.2 ± 87.5 NS 253.5 ±75.5N S N S
AHI (total sleep) 18,8 ± 7,3 10.0 ±4.3 .000∗∗∗ 7.3 ±3.3 .000∗∗∗ .001∗∗∗
sleep eﬃciency 82.0 ±9.38 8 .2 ±8.9 .001∗∗∗ 86.0 ±7.2 <001∗∗∗ .001∗∗∗
Minimum SaO2 72.0 ±7.98 4 .7 ±7.6 <001∗∗∗ 91.2 ±6.1 <001∗∗∗ <001∗∗∗
NREM (mins) 27.2 ±9.22 2 .3 ±7.2N S 2 5 .5 ±8.2N S N S
REM (mins) 63.4 ±18.28 2 .5 ±24.5 <001∗∗∗ 88.2 ±20.8 <001∗∗∗ <001∗∗∗
(0.PSG): First-night polysomnogram without using any appliance so as the baseline severity of OSA to be determined.
(PSG.K1): The ﬁrst week of control polysomnogram performed to group KW following 1-week insertion of the Klearway appliance.
(PSG.K2):Third control polysomnogram after one-month usage of Klearway appliance.
N = 12 Mean ± SD, mins = minutes, AHI = Apnea-hypopnea index, SaO2 = Minimum oxygen saturation, REM = Rapid eye movement, NREM = Nonrapid
eye movement;
∗P<. 05. ∗∗P<. 01. ∗∗∗P<. 001.
Table 2: Polysomnographicresults of mandibular advancement splint (MAS) group.
NORMS (N = 12) 0.PSG PSG.M1 0.PSG-PSG.M1 PSG.M2 0.PSG-PSG.M2 PSG.M1-PSG.M2
PP P
Total sleep time (mins.) 226.3 ±106.2 272 ±92.4 NS 253.5 ±88.5N S N S
AHI (total sleep) 17.9 ± 6.81 0 .0 ±4.5 .000∗∗∗ 9.1 ±4.9 .009∗∗∗ .009∗∗∗
Sleep eﬃciency 79.0 ±8.98 7 .4 ±8.0 .001∗∗ 88.0 ±9.2 <001∗∗∗ <001∗∗∗
Minimum SaO2 71.0 ±6.38 8 .2 ±6.5 <001∗∗∗ 90.1 ±7.8 <001∗∗∗ .01∗
NREM (mins) 25.2 ±8.12 6 .0 ±8.9N S 2 2 .2 ±7.3N S N S
REM (mins) 61.2 ±16.58 3 .2 ±19.8 .01∗ 87.4 ±22.8 <001∗∗∗ .001∗∗
(0.PSG): First-night polysomnogram without using any appliance so as the baseline severity of OSA to be determined.
(PSG.M1): The ﬁrst week of control polysomnogram performed to group MAS following 1-week insertion of the mandibular advancement splint appliance.
(PSG.M2): Third control polysomnogram after one-month usage of MAS appliance.
N = 12 Mean±SD, mins= minutes, AHI = Apnea-Hypopnea Index, SaO2 = Minimum oxygen saturation, REM = Rapid eye movement, NREM = Nonrapid
eye movement;
∗P<. 05. ∗∗P<. 01. ∗∗∗P<. 001.
diﬀerences were found between the baseline and ﬁrst week,
baseline and ﬁrst month in mean values of AHI for KW-mi,
KW-mo, MAS-mi, and MAS-mo groups (P< ,05). Besides,
the means of AHI for KW-mo and MAS-mo groups at the
end of the ﬁrst week and the ﬁrst month were found to be
statistically diﬀerent (P< ,05) in favour of the KW group
(Table 3).
The comparison between KW (KW-mi, KW-mo)and
MAS (MAS-mi, MAS-mo) groups of the mean AHI results
at the end of ﬁrst month and ﬁrst week has been given
in Table 4. Accordingly, the decrease in AHI of the KW-
mo group at the end of the 1st month was determined to
signiﬁcantlygreaterdiﬀerentthanthatoftheMAS-mogroup
(P = .019 <. 05).
The treatment success was deﬁned by resolution of
symptoms such as reduction in AHI <15 events/hr or at
least 50% reduction from baseline AHI [9]. The success rate
at the end of the ﬁrst week and ﬁrst month was shown in
Figure 3 for both groups. Reduction of AHI to <15events/hr
w a so b s e r v e di n7o ft h e1 2p a t i e n t s( 5 8 % )a tt h ee n do ft h e
1st week and 10 of the 12 patients (83.3%) at the end of the
1st month in group KW. The treatment success in 5 of 12
patients(42%)at theendofthe1st week and 8ofthe12OSA
patients (66.7%) at the end of the 1st month was observed in
MAS treatment group in our study.
1st month 1st week
0
10
20
30
40
50
60
70
80
90
(
%
)
Group KW
Group MAS
Figure 3 :T h es u c c e s sr a t e s( % )o ft h eg r o u p sa tt h ee n do ft h eﬁ r s t
week and ﬁrst month.
4.Discussion
In this study, the eﬀect of Klearway and MAS appliances on
OSApatientsatendof theﬁrst weekandﬁrst monthafter the
appliance insertion was evaluated. The results indicated thatISRN Dentistry 5
Table 3: The comparison of the AHI at diﬀerent time intervals for each groups. SE: Standard Error. Signiﬁcance level α =.05.
Groups 0.PSG—1-week-PSG mean
diﬀerence ± SE (AHI)
P
0.PSG—1-month-PSG
mean diﬀerence ± SE
(AHI)
P
1-week-PSG—1-month-
PSG mean diﬀerence ± SE
(AHI)
P
KW-mi 5.55 ± 0.8250 .000 6.75 ±0.8250 .000 1.25 ±0.8250 .266
KW-mo 12.083 ±0.9742 .000 16.333 ±0.9742 .000 4.2500 ±0.9742 .001
MAS-mi 4.41675 ±0.7662 .000 6.333 ±.07662 .000 1.9167 ±0.7662 ,089
MAS-mo 9.667 ± 0.9036 .000 11.1667 ±0.9036 .000 1.500 ±0.9036 ,046
Table 4: Comparison of the AHI between groups at diﬀerent time intervals. Signiﬁcance level α =.05.
Time KW-mi (AHI) MAS-mi (AHI) KW-mi/MAS-mi (AHI) KW-mo (AHI) MAS-mo (AHI) KW-mo/MAS-mo (AHI)
PP
1st week 6.6 ±2.27 .2 ±2.1 .552 13.5 ±3.01 4 .5 ±3.0. 4 3
1st/month 5.4 ±3.05 .3 ±2.7 .944 9.2 ±2.13 13.0 ±3.3 .019
both appliances were eﬀective in the treatment of snoring
and OSAS.Following Hanset al.’s[17] suggestionthat future
randomized clinical trials of dental devices for treatment of
OSAS and snoring should not use a placebo device as one of
the treatment groups, we did not use a control group or a
placebo device,
The diﬀerences between the two appliances were method
of retention and construction, ﬂexibility of material, adjusta-
bility, freedom of jaw movement, and quantity of the
mandibular protrusion. Both appliances were well tolerated
by all subjects. Although several side eﬀects including
excessive salivation, dryness of the mouth, and bruxism were
observed in both groups, these side eﬀects improved in a
week. Gum irritation was observed in 3 patients of group
MAS, but not in group KW. It could be the result of the
thermoelastic material the Klearway appliance was made of.
Tooth discomfort was seen in two patients of group KW.
This could be due to the increased retention of the Klearway
appliance. Some clinicians ﬁnd increased eﬀectiveness when
the lower jaw is rigidly stabilized like in the MAS [15], and
others feel that a slight degree of mobility enhances TMJ
comfort like in Klearway [10, 14]. Three of the 12 patients in
group MAS and 1 of the 12 patients in group KW described
mild pain around TMJ and muscle tenderness, respectively.
This complaints disappeared over time. De Almeida et al.
[18] had reported that OAs were safe regarding to TMJ
alterations in the treatment of patients with OSAS for one
year.
All patients subjectively reported more restful sleep with
a reduction of snoring. Indeed, initial EES score dropped
at the end of the ﬁrst month in both groups. On the other
hand, PSG data showed that mean REM time increased, and
there was no change in non-REM time during sleep in both
groups both at the end of the ﬁrst week and the ﬁrst month
while there was no change in total sleep time. In addition,
minimum oxygen saturation increased at the end of the ﬁrst
week and also increased above 90% oxygen saturation at the
e n do ft h eﬁ r s tm o n t hi nb o t hg r o u p s .
Optimal treatment of OSAS would result in abolition
of apnea and hypopnea, as can be achieved with nCPAP.
However, treatment might be considered adequate with
reduction of AHI below some deﬁned level. Mortality with
OSAS has been found to be signiﬁcantly increasing where
the number of apneas per hour of sleep exceeds twenty. In
the current study, the treatment success was deﬁned by a
resolution of symptoms, either by reduction of AHI to less
than 15events/hr or by at least a 50% reduction of AHI
compared to the baseline values [9, 18, 19]. Diﬀerent studies
using Klearway reported a treatment eﬃciency ranging from
50% to 80% [10, 14, 18, 20, 21]. Reduction of AHI to
<15events/hr was observed in 58% of patients at the end
of the 1st week and 83.3% of patients at the end of the
1st month in group KW. These results coincide with those
of Lowe et al. [14] who reported that 80% success rates
were achieved in mild OSA patients and 60% in more severe
OSA patients. On the other hand, reduction of AHI to
<15events/hr and relief of symptoms were evaluated as a
treatment success in 42% of patients at the end of the 1st
week and 66.7% of patients at the end of the 1st month in
MAS treatment group in our study. However, no statistically
signiﬁcant diﬀerence of the treatment success was found
between the KW and MAS group at the end of the ﬁrst week
and the ﬁrst month (P>. 05). These ﬁndings suggested
that K and MAS appliances had potentially useful role in the
treatment of OSA patients similar to each other. Our results
were similar with the previous studies [13, 14, 20]. On the
other hand, the reason for high success rates of both group
KW and group MAS patients at the end of the 1st month
compared to those of the 1st week could be explained by
gettingaccustomedtotheusageofappliances.Additionally,a
decrease was observedinthemean AHIresultsofthe KG-mo
and MAS-mo at the end of the ﬁrst month when compared
with AHI results of the ﬁrst week.
No statistical diﬀerence was found between the number
of patients in KW-mi and MAS-mi who reached AHI
reduction <15events/hr, both at the 1st week and the 1st
month. Although no statistically signiﬁcant changes in AHI
were observed between the KW-mo and MAS-mo in the
1st week (P>. 05), AHI was found to be statistically
diﬀerent for KG-mo and MG-mo at the 1st month (P<
.05). That is why MAS should be oﬀered as the treatment
of ﬁrst choice in relatively mild OSA patients, while the6 ISRN Dentistry
Klearway appliance can be recommended both to mild
and moderate OSA patients. However, in previous studies,
mandibular advancement appliances were proposed to mild
and moderate OSA patients [13, 19]. According to our
ﬁndings, we may recommend MAS appliance only to mild
OSA patients.
The correct therapeutic position of the mandible is
critical for the success of appliance in OSA patients, both
i nt e r m so fo p e n i n gt h ea i r w a ya sw e l la sp a t i e n tc o m f o r t
and compliance [5, 19, 22, 23]. Meurice et al. [23]r e p o r t e d
thatmouthopeningwaseﬀectiveinpharyngealcollapsibility.
However, Pitsis et al. [24] recently showed that altering the
amountofbiteopeningbyamandibularadvancementdevice
did not alter its polysomnographic eﬀects in patients with
OSA. Both MAS and Klearway were designed with 5mm
vertical opening and were found to be successful on the OSA
patients of this study.
DeAlmeidaetal. [18] evaluatedtherelationship between
diﬀerent increments of mandibular protrusion and AHI
after the insertion of titratable OA (Klearway). They found
that the reduction in the AHI depended on the amount
of mandibular protrusion. Lamont et al. [19]d e s i g n e dt w o
diﬀerent types of MAS. Type A device produced a maximum
mandibular protrusion with 3-4mm interincisal opening,
while type B permitted up to 70% mandibular protrusion
with 6–9mm vertical opening. They found that type B
device was more eﬀective on AHI than type A. The more
reduction of mean AHI in the KG-mo in comparison to the
reduction of those of MG-mo at the end of the ﬁrst month
could be attributed to the potential of Klearway appliance
to yield the desired amount of mandibular advancement.
However, the advancement of mandible was 75% of the
maximum mandibular protrusive capacity in group MAS.
Kuna et al. [16] suggested that if mandible was advanced to
85.2±25.8%ofmaximum voluntaryprotrusion by Klearway
appliance during treatment in OSA patients, acceptable
reduction in AHI couldbe obtained. Klearway appliance had
more advantage versus MAS appliance since the mandible
advanced slowly over time and allowed bone and soft tissue
structure to adjust this displacement in the meantime. On
the other hand, during the two years of OA treatment in
OSA patients, anatomic and occlusal changes were shown by
Bondemark [25]. Thus, two-year followup study to observe
the changes in TMJ anatomy during the AHI reduction
therapies must be done in the future.
There were method limitations in this study. The sample
size was small, and extrapolation of the results to a larger
population might be questionable for several reasons. The
eﬀects of long-term alteration in mandibular posture, TMJ,
and the oral tissues need to be investigated. The morbidity
associated with OSAS is of a chronic nature. Successful
management of chronic disease requires therapy that is
eﬀective over a period of years rather than a week or month.
5.Conclusion
Klearway and MAS appliances are both eﬀective in the
treatment of mild and moderate OSA patients.
An appliance (Klearway) that provides advancement of
85% of mandibular protrusion to openthe upperairway was
more eﬀective in reducing the number of high apneic events
during sleep than one (MAS) which provides 75%.
Mandibular advancement splint (MAS) should be pre-
ferred in mild OSA patients rather than moderate OSA
patients.
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